Loading…
Meridian Bioscience will increase production capacity of its SARS-CoV-2 molecular diagnostic test after receiving a $5.5M award from NIH and a grant from JobsOhio. The expansion includes a new facility in Newtown, Ohio, and will create 45 jobs, with maximum capacity of 800,000 tests per month by end of 2021.
“Our customers continue to search for more tests to battle this wave of the coronavirus pandemic and this support from our Federal, State and Local governments will be instrumental in scaling our manufacturing capacity.”meridianbioscience.com
Summarized from public sources; check the original articles before acting on it.